1. Genentech wants to double its San Francisco footprint — Biotechs with the biggest cash piles — Purdue Pharma wants to pay bonuses even under bankruptcy proceedings — See more on our front page news

    TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

Comp plan

Discussion in 'ConforMIS' started by anonymous, Jan 8, 2016 at 9:30 PM.

  1. anonymous

    anonymous Guest

    quotas are outrageous this year...I wonder how they decide 400% increase and commissions structured they way they are will attract, let alone keep, any decent talent here. Listen all you bracing and copier reps...here's a device company that will pay you less, and expect you to be happy. I'm sure the docs will appreciate someone who doesn't know the difference between a ligament and cartilage. Such a disappointment from a forward thinking (product-wise) company. Must be looking for a sale.
     
  2. anonymous

    anonymous Guest

    I find that 400% increase claim to be highly unlikely...
     
  3. anonymous

    anonymous Guest